| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.042 | 0.8 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |